Results 21 to 30 of about 88,639 (264)

Branch Retinal Vein Occlusion in a COVID-19 Positive Patient

open access: yesCureus, 2021
Retinal vein occlusions (RVOs), including central retinal vein occlusions (CRVOs) and branch retinal vein occlusions (BRVOs), are a common cause of morbidity in elderly patients.
S. Duff, M. Wilde, G. Khurshid
semanticscholar   +1 more source

Retinal Vein Occlusion Following Two Doses of mRNA-1237 (Moderna) Immunization for SARS-Cov-2: A Case Report

open access: yesOphthalmology and Therapy, 2021
Introduction Published data on possible ocular adverse events potentially associated with vaccination with the SARS-Cov-2 mRNA-1237 vaccine are scarce.
R. Sacconi   +3 more
semanticscholar   +1 more source

Ellipsoid Zone Defects in Retinal Vein Occlusion Correlates With Visual Acuity Prognosis: SCORE2 Report 14

open access: yesTranslational Vision Science & Technology, 2021
Purpose To evaluate the association between ellipsoid zone (EZ) on spectral domain optical coherence tomography (SD-OCT) and visual acuity letter score (VALS) in participants with retinal vein occlusion in the Study of Comparative Treatments for Retinal ...
Tyler Etheridge   +9 more
semanticscholar   +1 more source

Retinal vein occlusion in COVID-19: A novel entity

open access: yesIndian Journal of Ophthalmology, 2020
Coronavirus disease 2019 (COVID-19) is a form of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has been declared a pandemic by the World Health Organization (WHO).
J. Sheth   +3 more
semanticscholar   +1 more source

Platelet and Thrombophilia-Related Risk Factors of Retinal Vein Occlusion

open access: yesJournal of Clinical Medicine, 2021
Retinal vein occlusion (RVO) is a heterogenous disorder in which the formation of a thrombus results in the retinal venous system narrowing and obstructing venous return from the retinal circulation.
Adrianna Marcinkowska   +2 more
semanticscholar   +1 more source

Cytokines and Pathogenesis of Central Retinal Vein Occlusion

open access: yesJournal of Clinical Medicine, 2020
Central retinal vein occlusion (CRVO) causes macular edema and subsequent vision loss and is common in people with diseases such as arteriosclerosis and hypertension. Various treatments for CRVO-associated macular edema have been trialed, including laser
H. Noma, K. Yasuda, M. Shimura
semanticscholar   +1 more source

Central retinal vein occlusion with COVID-19 infection as the presumptive etiology

open access: yesIndian Journal of Ophthalmology, 2020
Thromboembolic phenomenon related to Coronavirus disease 2019 (COVID-19) has been well documented in literature; however, reported ocular manifestations of COVID-19 are limited to vision sparing ocular conditions like conjunctivitis.
J. Walinjkar   +4 more
semanticscholar   +1 more source

Retinal Vein Occlusions

open access: yesAsia-Pacific Journal of Ophthalmology, 2012
Retinal vein occlusions (RVOs) are second to diabetic retinopathy in the prevalence as retinal vascular disorder and are characterized by dilatation of the retinal veins with retinal and subretinal hemorrhages, macular edema, hard retinal exudates, retinal ischemia, and consequent atrophy of the retina and optic nerve.
Jost B, Jonas, Dennis S C, Lam
openaire   +2 more sources

Branch Retinal Vein Occlusion [PDF]

open access: yesThe Journal of Clinical Hypertension, 2003
The most common cause of branch retinal vein occlusion is hypertension. Since retinal arteries and veins share a common adventitial sheath, the thickened artery compresses a retinal vein causing an occlusion, resulting in a retinal hemorrhage. Most patients present in their 60s with unilateral involvement. The patient may be asymptomatic if the macula
Milan R, Patel   +2 more
openaire   +2 more sources

Retrospective, controlled observational case study of patients with central retinal vein occlusion and initially low visual acuity treated with an intravitreal dexamethasone implant [PDF]

open access: yes, 2016
Background Patients with initially low visual acuity were excluded from the therapy approval studies for retinal vein occlusion. But up to 28 % of patients presenting with central retinal vein occlusion have a baseline BCVA of less than 34 ETDRS letters (
Annabelle Eckert   +9 more
core   +2 more sources

Home - About - Disclaimer - Privacy